(Q43237260)

English

Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure

scientific article published on 26 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

endocannabinoid system

0 references

0 references

0 references

cannabinoid receptor

0 references

1 reference

based on heuristic

inferred from title

author name string

Florian Weis

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Andres Beiras-Fernandez

2

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ralf Sodian

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ingo Kaczmarek

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Bruno Reichart

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Andres Beiras

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Gustav Schelling

7

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Simone Kreth

8

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

26 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1187-1193

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Heart failure--an epidemic of uncertain proportions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

An introduction to the endocannabinoid system: from the early to the latest concepts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Targeting the endocannabinoid system: to enhance or reduce?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Endocannabinoids: synthesis and degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Endocannabinoids and the heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Release of anandamide from blood cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Effects of general anesthesia on anandamide blood levels in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Pitfalls in measuring the endocannabinoid 2-arachidonoyl glycerol in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Signaling pathways involved in the cardioprotective effects of cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

G protein-coupled receptor sorting to endosomes and lysosomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Cannabinoid receptors: where they are and what they do.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Cellular mechanisms in sympatho-modulation of the heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Beta-blockers to prevent symptomatic heart failure in patients with stage A and B heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Potential role and mechanisms of subcellular remodeling in cardiac dysfunction due to ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Systemic inflammation in heart failure--the whys and wherefores

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Receptors for acylethanolamides-GPR55 and GPR119

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

The enigmatic pharmacology of GPR55

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.10.025

7 January 2021

Identifiers

10.1016/J.YJMCC.2009.10.025

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43237260&oldid=1984661803"